Acute intermittent porphyria in two patients on anticonvulsant therapy and with normal erythrocyte porphobilinogen deaminase activity.

1. Acute intermittent porphyria (AIP) is sometimes termed a 'pharmacogenetic' disease. patients with genetic deficiency of the enzyme porphobilinogen deaminase are liable to develop acute attacks of porphyria if exposed to a variety of drugs. 2. Two patients are reported who had no evidenc...

Full description

Saved in:
Bibliographic Details
Main Authors: Herrick, A L, McColl, K E, Moore, M R, Brodie, M J, Adamson, A R, Goldberg, A
Format: Artigo
Language:Inglês
Published: 1989
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1379729/
https://ncbi.nlm.nih.gov/pubmed/2497768
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items